Entérobactéries productrices de bêta-lactamases à spectre étendu en pédiatrie
暂无分享,去创建一个
[1] A. Birgy,et al. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in french children , 2012, BMC Infectious Diseases.
[2] A. Birgy,et al. In Vitro Interaction between Cefixime and Amoxicillin-Clavulanate against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Causing Urinary Tract Infection , 2012, Journal of Clinical Microbiology.
[3] G. Peirano,et al. Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian Region , 2011, Journal of Clinical Microbiology.
[4] Evangelos I. Kritsotakis,et al. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. , 2011, The Journal of antimicrobial chemotherapy.
[5] Y. Buisson,et al. High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar , 2010, BMC infectious diseases.
[6] G. Peirano,et al. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. , 2010, International journal of antimicrobial agents.
[7] K. Laupland,et al. Molecular Characteristics of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections , 2009, Antimicrobial Agents and Chemotherapy.
[8] C. Chiu,et al. Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Children With Vesicoureteral Reflux Receiving Prophylactic Antibiotic Therapy , 2008, Pediatrics.
[9] J. Lemeland,et al. CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. , 2008, The Journal of antimicrobial chemotherapy.
[10] A. Oliver,et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. , 2008, Archives of internal medicine.
[11] F. Baquero,et al. High Rate of Intestinal Colonization with Extended-Spectrum-β-Lactamase-Producing Organisms in Household Contacts of Infected Community Patients , 2008, Journal of Clinical Microbiology.
[12] J. Madec,et al. Prevalence of Fecal Carriage of Acquired Expanded-Spectrum Cephalosporin Resistance in Enterobacteriaceae Strains from Cattle in France , 2008, Journal of Clinical Microbiology.
[13] J. Blanco,et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.
[14] D. Paterson. Treatment of ESBL producers , 2007 .
[15] R. Cantón,et al. The CTX-M β-lactamase pandemic , 2006 .
[16] A. Philippon,et al. Epidemiology of extended spectrum β-lactamases , 1989, Infection.
[17] W. Craig,et al. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] R. Bonnet. Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes , 2004, Antimicrobial Agents and Chemotherapy.
[19] Victor L. Yu,et al. Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory , 2001, Journal of Clinical Microbiology.
[20] P. Desjardins,et al. Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital , 1993, Journal of clinical microbiology.
[21] C. Bizet,et al. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. , 1989, The Journal of infectious diseases.